Liquidia LQDA
NASDAQ LQDA
$71.08 -4.25 (-5.64%)
As of: Aug 20, 2026 · 3:59 PM EDT

Liquidia (LQDA) EPS (Diluted) (2020 - 2026)

Liquidia (LQDA) EPS (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn -0.49
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 2.07
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 0.45
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 7.27
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn -0.10
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 1.39
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 0.11
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Liquidia 6.31 Bn 6.03 Bn 160.92 Mn 0.74

Historic Data

Download Data
DateValue
Jun 30, 2026 0.74
Mar 31, 2026 0.52
Dec 31, 2025 0.17
Sep 30, 2025 -1.74
Jun 30, 2025 -1.22
Mar 31, 2025 -0.45
Dec 31, 2024 -0.49
Sep 30, 2024 -0.96
Jun 30, 2024 -1.22
Mar 31, 2024 -1.62
Dec 31, 2023 -0.42
Sep 30, 2023 -0.48
Jun 30, 2023 -0.82
Mar 31, 2023 -0.48
Dec 31, 2022 -0.08
Sep 30, 2022 -0.30
Jun 30, 2022 -0.23
Mar 31, 2022 -0.30
Dec 31, 2021 -0.23
Sep 30, 2021 -0.26